Skip to main navigation Skip to search Skip to main content

A Multicenter, Open-Label, Phase 1a/b First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of BG-C0979 in Patients with Selected Advanced Solid Tumors

  • Bhave, Prachi (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date10/04/26 → 9/04/28

Keywords

  • Clinical Trials
  • Phase 1a/b
  • BG-C0979
  • Advanced Solid Tumors

Clinical Trial Phase

  • Phase I
  • External Sponsor